Search research articles
Contact Us
Filters
Showing results (51-60 of 122) with videos related to
Page
of 13
Sort By:
Leukemia & Lymphoma
|
April 15, 2016
Acute and late toxicity of bilateral orbital irradiation in the management of primary intraocular lymphoma
Sarah A Milgrom, Chan Y Cheah, Chelsea C Pinnix, et al.
Hemasphere
|
June 9, 2026
Obinutuzumab, lenalidomide, and venetoclax for the initial treatment of patients with advanced-stage follicular lymphoma: Results of the Phase Ib/II LEVERAGE study
Chan Y Cheah, Piers Blombery, Amanda Johnston, et al.
Leukemia & Lymphoma
|
October 15, 2015
Dose-reduced fludarabine, cyclophosphamide and rituximab is well tolerated in older patients with chronic lymphocytic leukemia and has preserved therapeutic efficacy
Thomas E Lew, Chan Y Cheah, Dennis A Carney, et al.
Internal Medicine Journal
|
August 5, 2024
Diagnosis, management and follow-up of follicular lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance
Joshua W D Tobin, Greg Hapgood, Anna Johnston, et al.
British Journal of Haematology
|
April 18, 2024
Primary gastric diffuse large B-cell lymphoma: A multicentre retrospective study
Cameron S Lewis, Greta Joy, Paw Jensen, et al.
British Journal of Haematology
|
March 3, 2023
Outcomes of human immunodeficiency virus-associated Burkitt lymphoma and diffuse large B-cell lymphoma treated in Australia: A report from the Australasian Lymphoma Alliance
Kenneth J C Lim, Pietro Di Ciaccio, Mark N Polizzotto, et al.
Nature Reviews. Clinical Oncology
|
November 2, 2024
Navigating the changing landscape of BTK-targeted therapies for B cell lymphomas and chronic lymphocytic leukaemia
Michele D Stanchina, Skye Montoya, Alexey V Danilov, et al.
Blood Advances
|
July 28, 2022
Enrichment of BTK Leu528Trp mutations in patients with CLL on zanubrutinib: potential for pirtobrutinib cross-resistance
Piers Blombery, Ella R Thompson, Thomas E Lew, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 22, 2023
Characteristics and Outcomes of Older Patients With Classical Hodgkin Lymphoma: An Australasian Lymphoma Alliance, and Lymphoma and Related Diseases Registry Study
Zhong Goh, Maya Latimer, Katharine L Lewis, et al.
Hemasphere
|
October 24, 2025
EHA-EU MCL network guidelines for diagnosis and treatment of mantle cell lymphoma
Mats Jerkeman, Igor Aurer, Elias Campo, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 122) with videos related to
Sort By:
Page
of 13
Leukemia & Lymphoma
|
April 15, 2016
Acute and late toxicity of bilateral orbital irradiation in the management of primary intraocular lymphoma
Sarah A Milgrom, Chan Y Cheah, Chelsea C Pinnix, et al.
Hemasphere
|
June 9, 2026
Obinutuzumab, lenalidomide, and venetoclax for the initial treatment of patients with advanced-stage follicular lymphoma: Results of the Phase Ib/II LEVERAGE study
Chan Y Cheah, Piers Blombery, Amanda Johnston, et al.
Leukemia & Lymphoma
|
October 15, 2015
Dose-reduced fludarabine, cyclophosphamide and rituximab is well tolerated in older patients with chronic lymphocytic leukemia and has preserved therapeutic efficacy
Thomas E Lew, Chan Y Cheah, Dennis A Carney, et al.
Internal Medicine Journal
|
August 5, 2024
Diagnosis, management and follow-up of follicular lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance
Joshua W D Tobin, Greg Hapgood, Anna Johnston, et al.
British Journal of Haematology
|
April 18, 2024
Primary gastric diffuse large B-cell lymphoma: A multicentre retrospective study
Cameron S Lewis, Greta Joy, Paw Jensen, et al.
British Journal of Haematology
|
March 3, 2023
Outcomes of human immunodeficiency virus-associated Burkitt lymphoma and diffuse large B-cell lymphoma treated in Australia: A report from the Australasian Lymphoma Alliance
Kenneth J C Lim, Pietro Di Ciaccio, Mark N Polizzotto, et al.
Nature Reviews. Clinical Oncology
|
November 2, 2024
Navigating the changing landscape of BTK-targeted therapies for B cell lymphomas and chronic lymphocytic leukaemia
Michele D Stanchina, Skye Montoya, Alexey V Danilov, et al.
Blood Advances
|
July 28, 2022
Enrichment of BTK Leu528Trp mutations in patients with CLL on zanubrutinib: potential for pirtobrutinib cross-resistance
Piers Blombery, Ella R Thompson, Thomas E Lew, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 22, 2023
Characteristics and Outcomes of Older Patients With Classical Hodgkin Lymphoma: An Australasian Lymphoma Alliance, and Lymphoma and Related Diseases Registry Study
Zhong Goh, Maya Latimer, Katharine L Lewis, et al.
Hemasphere
|
October 24, 2025
EHA-EU MCL network guidelines for diagnosis and treatment of mantle cell lymphoma
Mats Jerkeman, Igor Aurer, Elias Campo, et al.
Page
of 13